Tablet-based Application for Cognitive Therapy

Status Recruiting

Clinical Trial Summary

Cognitive impairments such as deficits in attention, executive functions, perception, language, speech, arithmetics, and memory are very common symptoms after acquired brain injury, which can be caused by neurological diseases such as stroke, cerebral haemorrhage or traumatic brain injury. Around 83% of patients with brain injury suffer from a sequelae of cognitive impairments. Since the effects caused by neurological diseases can vary greatly from person to person, intensive and individual neuro-rehabilitation is necessary to help patients return to an independent life in the best possible way. In the DACH area (i.e., in Germany, Austria, and Switzerland), patients with cognitive impairments following brain injuries generally receive this intensive and interdisciplinary treatment while being hospitalised in an inpatient clinic following acute medical care. However, once they leave inpatient care facilities, there are insufficient treatment options readily available to them due to limitations/shortages in the healthcare system's resources, although studies indicate that an increase in therapy time (both in outpatient settings at home or in care facilities) enables greater, long-term rehabilitation progress and faster reintegration and participation in everyday life. Thanks to recent technical advancements, digital treatment options now promise the availability of sufficiently frequent and intensive treatment outside of clinic settings. In that context, the myReha therapy software (available as an app on iOS ad Android tablets), a certified medical device, was developed to enable patients to receive individualised and intensive therapy regardless of the healthcare system's constraints. To test the effectiveness of the myReha therapy software, in this two-arm, randomised, controlled study, patients in the intervention group receive treatment through the myReha therapy software in addition to their usual standard care (i.e., care-as-usual - CAU), while the control group only receives CAU. Treatment outcomes (i.e., rehabilitation progress) are measured based on the CERAD-plus.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Brain Injuries

Clinical Trial Details

NCT number	NCT06462703
Study type	Interventional
Source	Klinikum Floridsdorf
Contact
Status	Recruiting
Phase	N/A
Start date	March 2, 2023
Completion date	June 1, 2025

View Details

See also
Status	Clinical Trial	Phase
Enrolling by invitation	`NCT05542108` - Adding Motion to Contact: A New Model for Low-cost Family Centered Very-early Onset Intervention in Very Preterm-born Infants	N/A
Completed	`NCT03400904` - Extubation Strategies in Neuro-Intensive Care Unit Patients and Associations With Outcome.
Completed	`NCT06073145` - Transcranial Doppler Using Wearable Ultrasound Patch
Recruiting	`NCT03899532` - Remote Ischemic Conditioning in Traumatic Brain Injury	N/A
Recruiting	`NCT06010823` - Safety and Efficacy Evaluation of the Robotic Enhanced Error Training of Upper Limb Function in Post-stroke and Post TBI Participants	N/A
Not yet recruiting	`NCT05833568` - Five-day 20-minute 10-Hz tACS in Patients With a Disorder of Consciousness	N/A
Withdrawn	`NCT04288076` - The Brain and Lung Interaction (BALI) Study	N/A
Not yet recruiting	`NCT02756585` - Computed Tomography Perfusion in Patients With Severe Head Injury	N/A
Completed	`NCT03162484` - Physical Activity and Chronic Acquired Brain Injury	N/A
Terminated	`NCT01430988` - Observational Study of the BrainScope® Ahead™ M-100 in UK Emergency Department Patients With Head Injury	N/A
Completed	`NCT01093053` - Mind-Body Skills Groups for the Treatment of War Zone Stress in Military and Veteran Populations	N/A
Completed	`NCT00975338` - The LETS Study: A Longitudinal Evaluation of Transition Services
Completed	`NCT00878631` - Feasibility Trial of Traumatic Brain Injured Patients Randomized in the Prehospital Setting to Either Hypertonic Saline and Dextran Versus Normal Saline	Phase 2/Phase 3
Completed	`NCT03166722` - Cerebral Regional Tissue Oxygen Saturation to Guide Oxygen Delivery in Preterm Neonates During Immediate Transition	N/A
Not yet recruiting	`NCT04478812` - Tbit System Precision and Correlation of Different Blood Samples	N/A
Recruiting	`NCT05443542` - VIrtual Reality in Cognitive Rehabilitation of Processing Speed for Persons With ABI	N/A
Recruiting	`NCT05309005` - Virtual Reality and Social Cognition After Acquired Brain Injury
Completed	`NCT02702635` - Measuring Blood Flow Characteristics Using Dynamic Contrast Enhanced Magnetic Resonance Imaging	N/A
Withdrawn	`NCT04247321` - Non-invasive Near-infrared Spectroscopy (NIRS) Versus Invasive Licox Intracranial Pressure	N/A
Not yet recruiting	`NCT04386525` - Omega 3 and Ischemic Stroke; Fish Oil as an Option	Phase 4

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Tablet-based Application for Cognitive Therapy — TACTIC

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms